Doses were selected to determine the efficacy of the new ASD formulation of FBZ after oral administration for 5 days, which is considered a dosing regimen feasible for use in patients in the field as well as on the basis of previous pharmacokinetic and toxicological data.
![[This page as RDF]](http://data.gesis.org/somesci/static/rdf-icon.gif){kind=icon}